Phase III trial for Isolagen Therapy completed

Journal of Drugs in Dermatology, March, 2008 by Marissa Heller

Isolagen, Inc has announced that injection treatments have been completed in its phase III double-blind, randomized, placebo-controlled, clinical trials: IT-A-005 and IT-A-006. All patients who have completed treatments may now advance to the follow-up period of the study. These trials have examined Isolagen Therapy[TM] in the treatment of nasolabial folds.

In addition, Isolagen has completed injections in the phase II study of Isolagen Therapy for full-face treatments, which was designed to gather safety data. These patients have also advanced to the follow-up period.

COPYRIGHT 2008 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale